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Abstract
Introduction. Research in the ﬁeld of protein-bound phosphohistidine phosphorylation has been hampered by the difﬁculties in
analysis and detection of phosphohistidine. Therefore a screening method was developed primarily for the analysis of
phosphohistidine phosphatase 1 (PHPT1) activity.
Methods. A highly positively charged substrate, Ac-Val-Arg-Leu-Lys-His-Arg-Lys-Leu-Arg-pNA, containing the peptide
surrounding the phosphorylated histidine in ion channel KCa3.1 was chemically phosphorylated using phosphoramidate.
Excess phosphoramidate was removed by anion exchange chromatography using a micro spin column. After incubation of the
eluate with PHPT1, the removed phosphate was bound on a consecutive anion exchange spin column. The eluate was assayed
in a micro plate format for remaining phosphate in the substrate Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA. Histone
H4, also highly positive in charge, was subjected to the same procedure to explore the possibility to use other substrates to
PHPT1 in this assay format.
Results. It was found that Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA and phosphohistone H4 were dephosphorylated
by PHPT1. The apparent Km for Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA was in the order of 10 mM.Using this
method, phosphohistidine phosphatase activity was detected in mouse liver cell sap with Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-
Leu-Arg-pNA as substrate.
Discussion. The described method for determination of PHPT1 activity is comparably much easier and faster than presently
used methods for detection of phosphohistidine phosphatase activity. It is also sensitive, since the lower activity limit was
5 pmol phosphate released per min. It has the potential to be used both for more rapid screening for inhibitors and activators to
phosphohistidine phosphatases and for screening of histidine kinases.
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Introduction
The formation and degradation of protein-bound
phosphohistidine has met with increased interest dur-
ing recent time (see Klumpp et al. (1) and references
therein). Instrumental in this development has been
the discovery, independently by two groups, of a
mammalian phosphohistidine phosphatase (PHPT1),
also referred to as protein histidine phosphatase (2,3).
I ts e e m st ob eu b i q u i t o u s l ye x p r e s s e d ,w i t ha n
especially high expression on dividing epithelial
cells (4).
Essential issues in the current studies on PHPT1
are the identiﬁcation of its natural substrates
and the development of convenient methods for
its assay. One problem connected with these tasks is
due to the well known lability of phosphohistidine
at acid conditions, which may also partly explain
the rather slow pace of phosphohistidine-related
research, despite the early discovery of protein-bound
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DOI: 10.3109/03009734.2011.585253phosphohistidine by Boyer et al. in 1962 (5). Another
problem in developing assays for PHPT1 is that
the substrates identiﬁed so far are either dephosphory-
lated at low rates or require quite laborious assay
procedures, or both. Therefore, a simpler assay was
attempted, as described in the present work.
The standard substrate for PHPT1 used so far by us
is the peptide succinyl-Ala-His(P)-Pro-Phe-p-nitro-
anilide, where a comparatively time-consuming
HPLC is required forthe separationof phosphorylated
and dephosphorylated peptide (2). With this assay,
using7 mM phosphopeptide, thepure pigliverPHPT1
displayed an activity of 3 mmolmin
-1mg
-1, and the
human recombinant PHPT19 mmolmin
-1mg
-1.With
1 mM phosphoramidate as substrate, the rate was
0.6 mmolmin
-1mg
-1 for the pig liver enzyme.
In their original work on rabbit liver PHPT1,
Klumpp et al. (3) used the bacterial autophosphory-
lated chemotaxis protein A (CheA) as substrate, at a
concentration of 5 mM, which gave a speciﬁc activity
of the pure enzyme of only about 12 pmolmin
-1mg
-1,
i.e. at least ﬁve orders of magnitude lower than the
values obtained by Ek et al. (2).
Later, Klumpp and co-workers identiﬁed phos-
phorylated ATP citrate lyase (ACL) and b-subunit
of G-protein (Gb) as substrates of PHPT1 (6,7). Gb is
phosphorylated by the action of NDPK-B, as detailed
in Wieland et al. (8). The Mg
2+-dependent phosphor-
ylation of puriﬁed ACL occurs either by autopho-
sphorylation or by nucleoside diphosphate kinase A
(NDPK-A), while ACL in a crude rat liver extract can
be phosphorylated also in the presence of EDTA
(cf. Wagner (9)). We would suggest that the phos-
phorylation of ACL in EDTA-containing crude
extracts may be explained by the phosphoryl transfer
from NDPK-A, which can be autophosphorylated
also in EDTA, although at a considerably lower rate
than that obtained at excess of Mg
2+ (cf. Wålinder
et al. (10)). The analyses of phosphorylated substrates
were in all three cases SDS-PAGE followed by auto-
radiography after phosphorylation with radiolabelled
ATP. No speciﬁc activities of PHPT1 for these two
substrates are reported, but the rate of dephosphory-
lation appears to be quite low. A detailed description
of their methods and the interplay between NDPK
and PHPT1 were given by Wieland et al. (8).
In a joint project with the group of Kowluru the
Klumpp group has also indicated a role for PHPT1
in insulin secretion in pancreatic b-cells (11), and
together with Attwood and Besant and co-workers
they have, using NMR, shown a dephosphorylation by
PHPT1 of phosphoramidate and of chemically phos-
phorylated peptides representing the amino acid
sequences around the two histidine residues (His-18
and His-75) of histone H4 (12). The estimated rates of
dephosphorylation seem to be of the same order as
reported for phosphoramidate and Suc-Ala-His(P)-
Pro-Phe-pNA by Ek et al. (2).
The clearest demonstration so far of a physiological
role of PHPT1 in regulatory protein phosphorylation
has been reported by the group of Skolnik which has
shown that the potassium channel KCa3.1 in human
CD4 T lymphocytes is activated in a NDPK-B-
dependent phosphorylation (13) and is inactivated
by the action of PHPT1 (14). The phosphorylation
of KCa3.1 takes place at histidine 358. This residue is
located in the carboxyl terminus of KCa3.1 and is
surrounded by several basic residues, in the sequence
Val-Arg-Leu-Lys-His-Arg-Lys-Leu-Arg.
Given this background, we chose to make use of the
highly basic nature of this sequence and tested
the chemically phosphorylated peptide acetyl-Val-
Arg-Leu-His(P)-Arg-Lys-Leu-Arg-para-nitroanilide
(Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA)
as a substrate for PHPT1. The addition of the
N-terminalacetylgroupwasaimedtopreventanattack
of aminopeptidases in crude cell extracts, and the
C-terminal para-nitroanilide group was both aimed
to prevent the action of carboxypeptidases and to
facilitate a sensitive and quantitative tracing of the
substrate. Phosphorylation was achieved chemically
by incubation with phosphoramidate. The phosphate
in the product after incubation with enzyme was mea-
sured by a malachite method after removal of excess
phosphoramidate and released phosphate on DEAE-
Sephacel micro spin columns.
Recently, Attwood et al. reported that PHPT1
appeared unable to dephosphorylate histone H4
that had been phosphorylated with a thymus histidine
kinase (12). However, since histone H4 contains two
histidine residues (His-18 and His-75) and either
1-phosphohistidine or 3-phosphohistidine can occur
depending on the source of the histidine kinase (15),
there may be as much as four possible ways to mono-
phosphophorylate histone H4. If only one of these
versions represents the product of the thymus histi-
dine kinase, there is still a possibility that at least one
of the remaining versions can be dephosphorylated by
PHPT1. Assuming that the chemical phosphorylation
of histone H4 by phosphoramidate can give rise to
more than one variant of histidine-phosphorylated
histone H4 (16,17), we applied the new assay des-
cribed in this report in an investigation of the dephos-
phorylation by PHPT1 of chemically phosphorylated
histone H4, also highly positive in charge. This was
also performed in order to investigate if the method
can be used for other positively charged phosphohis-
tidineproteins of interest instead of the peptide in
future research in the ﬁeld of phosphorylation-
dephosphorylation of histidine.
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Materials
DEAE-Sephacel and Sephadex G-50 were from GE-
Health Care, Sweden. Micro Bio-Spin columns were
obtained from BioRad, USA. Ac-Val-Arg-Leu-Lys-
His-Arg-Lys-Leu-Arg-pNA and Ac-Val-Arg-Leu-
Lys-Ala-Arg-Lys-Leu-Arg-pNA were synthesized by
Genscript, USA by order. Malachite green reagent
was from Bie-Berntsen, Denmark. Antibodies raised
in rabbit against histone H4 were from Upstate, USA.
Secondary polyclonal swine anti-rabbit antibodies,
conjugated with alkaline phosphatase, were from
Dako, Denmark and 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) was from Sigma, USA. Non-radio-
active phosphoramidate was synthesized by applying
the method described for [
32P]phosphoramidate by
Buckler and Stock (18). It was lyophilized and stored
at -20C until use, when it was dissolved in deionized
water to a concentration of 0.2 M. Solutions of phos-
p h o r a m i d a t ew e r et h e ns t o r e da t- 8 0 Ci na l i q u o t s
that were thawed only once before use. Human recom-
binant phosphohistidine phosphatase (PHPT1) was
expressed and puriﬁed as described by Ma et al.
(19). Human recombinant histone H4 was from
New England Biolabs, UK. The recombinant protein
was delivered, at 1 mg/mL, in 20 mM sodium phos-
phate (pH 7.0), 300 mM NaCl, 1 mM EDTA, and
1 mM dithiothreitol. Before use, this solvent was
changed by centrifugation of 50 mL aliquots through
a2 1 0mL DEAE-Sephacel gel equilibrated in 10 mM
HCl for2 min at 900 g according to the manufacturer’s
instruction. Histone Type II-S, which has a high con-
centration of histone H4, was from Sigma and was
further puriﬁed as described below. All peptides aimed
atESI-ms(-ms) were pre-puriﬁed on C18 tipsobtained
from Eppendorf Ltd, UK according to instructions.
After elution in usually 10 mL of 60% acetonitrile/1%
acetic acid, aliquots of 2 mL were transferred to spray
needles (New Objective Inc., USA). Analysis was
performed manuallyandimmediately after puriﬁcation
inordertolimitdephosphorylationintheacidsolution.
Analysis was on a LTQ-ft Ultra (Thermo Scientiﬁc,
Germany).SpectrawerefurtheranalysedinthemMass
software (20).
Methods
MALDI-TOF mass spectrometry was performed by
Dr Åke Engström at the Department of Medical
Biochemistry and Microbiology. UV-absorption was
measured by use of a NanoDrop2000c Spectropho-
tometer from Thermo Scientiﬁc. Mouse liver cytosol
was prepared by the small-scale method, as described
for pig liver cytosol (2), except that 1 mM Pefabloc
was used instead of diisopropyl ﬂuorophosphate as a
protease inhibitor.
Puriﬁcation of histone H4. Calf thymus histone
Type II-S (Sigma), 0.5 mL of a 40 mg/mL solution
in 8 M urea/10 mM HCl, was chromatographed on a
20 mL (0.5  25 cm) Sephadex G-50, equilibrated,
and eluted with 10 mM HCl. Fractions were analysed
by SDS-PAGE and Western blot as described below,
and peak fractions containing histone H4 were used
for further experiments. The pooled material was
diluted in 10 mM HCl, to a histone H4 concentration
of 1 mg/mL and was kept at -20C until use.
Equilibration of DEAE-Sephacel. DEAE-Sephacel was
left to sediment, decanted and equilibrated in 25 mM
Tris/HCl, pH 8.0 for peptides and pH 8.5 for histone
H4. The ﬁnal suspension was 60% (v/v). Micro Bio-
Spin columns were packed with a predetermined
volume of the suspension that depended on the vol-
ume of the sample (generally 700 mL for samples of
400–525 mL and 350 mL for samples of 50–250 mL)
and centrifuged for 10 s at 900 g. Then 500 mLo ft h e
equilibration buffer was added to the columns fol-
lowed by centrifugation for 1 min at 900 g.
Histidine phosphorylation of peptides and histone H4.
Aliquots of 25 mL of peptide solutions (generally
1 mM) were mixed with 25 mL 25 mM Tris/HCl,
pH 8.0, and incubated with 1 mL 0.2 M phosphor-
amidate at room temperature for the indicated times.
Similarly, 25-mL aliquots of a solution of histone
H4 (1 mg/mL, 88 mM) in 10 mM HCl were mixed
with 25 mM Tris/HCl, pH 8.5 to give pH 7.8, and
incubated with 1 mL 0.2 M phosphoramidate for 48 h
at room temperature.The incubation was interrupted
by freezing at -80C or, if immediately used, by
centrifugation on 200 mL DEAE-Sephacel Micro
Bio-Spin columns for 2 min at 900 g. Tween
20 was added to a ﬁnal concentration of 0.02%
(v/v) before the centrifugation step to improve the
recovery of phosphohistone. The eluted volume was
centrifuged on a second gel after another addition of
Tween to 0.02%, and the eluate was used for further
experiments. The volume of the samples increased by
2%–4% during these procedures; a sample of 50 mL
increased to 52–54 mL after centrifugation. This gen-
eral procedure using the Micro Bio-Spin columns
could also be adapted for larger incubation volumes.
Dephosphorylation of phosphorylated peptides and histone
H4. Aliquots of 50 mL of the eluates from the Micro
Bio-Spin columns were incubated at 30C with 1 mL
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for varied times. Tween 20 was added to a ﬁnal
concentration of 0.02% and was present during the
dephosphorylation. The incubations were interrupted
by centrifugation for 2 min at 900 g on 210 mL DEAE-
Sephacel Micro Bio-Spin columns. The eluate was
analysed for acid-labile phosphate as described below.
The absorbance at 320 nm and a molar absorbance of
6050 M
-1cm
-1 was used to determine the recovery of
phosphorylated and unphosphorylated peptides. The
recovery of total histone H4 was determined by mea-
suring the absorbance at 280 nm, using the A280 value
0.524 for 1 mg/mL and a light-path of 1 cm.
Phosphate analysis. The eluate was analysed for phos-
phate using malachite green reagent. The acid milieu
of this reagent (1 M HCl) permitted the analysis of
acid-labile, N-linked phosphate. Thus, a sample of
50 mL was incubated with 50 mL of the malachite
green reagent for minimally 2 h at room temperature
in micro plates. This time was sufﬁcient to release all
of the acid-labile phosphate as orthophosphate. The
absorbance was measured at 620 nm, and the amount
of phosphate was calculated using standards from 0 to
2 nmol phosphate in 50 mLH 2O where each pmole
phosphate gave an absorbance of 0.0002, so the lower
sensitivity limit was in the order of 2–5 pmoles/
min under the condition used. All buffers used in
this study were tested as diluents of the standards,
with the same results. The coefﬁcients of correlation
for the standard curves were always above 0.99.
SDS-PAGE. SDS-PAGE was performed in 12%
polyacrylamide gels in accordance with standard pro-
tocols, and the gels were stained with Coomassie
brilliant blue.
Western blot. The proteins in an unstained SDS-
PAGE gel were transferred to a nitrocellulose mem-
brane using a semi-dry transfer cell from BioRad
according to their instructions. Coating was per-
formed in a buffer containing 5% (w/v) dry milk,
and the dilution of anti-histone H4 antibodies was
1/10,000. An alkaline phosphatase-conjugated anti-
rabbit IgG and BCIP were used for detection of
histone H4 according to the instructions from the
manufacturer.
Results and discussion
Phosphorylation of peptides and histone H4 by
phosphoramidate
As mentioned in the Introduction, we ﬁrst chose
to work with a peptide representing the site around
the phosphorylatable histidine 358 in the calcium-
stimulated potassium channel KCa3.1 (14). From the
progress of the phosphorylation of 0.5 mM Ac-Val-
Arg-Leu-Lys-His-Arg-Lys-Leu-Arg-pNA (Figure 1),
it is concluded that an incubation time of more than
24 h would not signiﬁcantly increase the phosphory-
lation level above the generally obtained 0.15 mol
phosphate per mol of peptide. Therefore, this incu-
bation time was chosen for standard preparations.
The about 3-fold lower level of histidine phosphory-
lation, compared to what may be expected from the
peptide phosphorylation by phosphoramidate descri-
bed by Attwood et al. (12), may be partly explained by
the 10- and 20-fold lower initial concentrations of the
basic peptide and phosphoramidate, respectively, in
our experiments, which should also give lower rates
of phosphorylation. In addition, the phosphorylated
peptide is labile in itself at pH 8.0, which may
further decrease the net rate of the chemical phos-
phorylation. Finally, due to the lability of phosphor-
amidate (12,18), its concentration is gradually
decreased during the incubation. Still, the low initial
concentration of phosphoramidate (3.9 mM) was a
deliberate choice in order not to exceed the binding
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Figure 1. Phosphorylation of peptides by phosphoramidate as a
function of time. The concentration of Ac-Val-Arg-Leu-Lys-His-
Arg-Lys-Leu-Arg-pNA and Ac-Val-Arg-Leu-Lys-Ala-Arg-Lys-
Leu-Arg-pNA was 0.5 mM and that of phosphoramidate
3.9 mM. The incubation was performed at room temperature
and interrupted by centrifugation of 50 mL of the reaction mixture
through two consecutive spin columns containing 210 mL DEAE-
Sephacel equilibrated in 25 mM Tris/HCl, pH 8.0. The phosphate
and peptide concentration in the ﬁnal eluate was determined by
malachite reagent and by measuring the absorbance at 320 nm,
respectively. The values are given as means of duplicate analysis.
(^) Ac-Val-Arg-Leu-Lys-His-Arg-Lys-Leu-Arg-pNA and (&)
Ac-Val-Arg-Leu-Lys-Ala-Arg-Lys-Leu-Arg-pNA. Details are given
in Material and methods.
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below).
Under the same conditions, the control peptide
Ac-Val-Arg-Leu-Lys-Ala-Arg-Lys-Leu-Arg-pNA dis-
played a background phosphorylation of 0.05 mol/s/
mol enzyme, despite its lack of histidine. The nature of
this phosphorylation and the phosphorylation ratio
between the two were determined using mass spec-
trometry. Several forms (i.e. charges) of the peptide
were found. For the His-containing peptide two dif-
ferently charged phosphorylated variants were seen
(+3 and +4). The nature of the phosphohistidine
isomer in Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-
Arg-pNAwasnotdetermined,butitwasconsideredto
be 3-phosphohistidine, rather than 1-phosphohisti-
dine, due to the 24 h phosphorylation time used
(12,21,22). By using both ion-trap for fragmentation
and analysis it was possible to detect a complete
y-series for the phosphorylated peptide (not shown).
When ion-cyclotron analysis was attempted, only par-
tial serieswereobtained even inthecasefragmentation
was by electron-capture dissociation (ECD).
For the Ala-peptide an almost complete y-series
was seen indicating that the Lys in position 7 was
phosphorylated. Scrutinizing the spectra, a short
stretch of the b-series could also be seen (b4, b5,
and b6), and this showed that also the Lys in position
4 was phosphorylated. No doubly phosphorylated
peptides were seen, but the reason for this could be
difﬁculties in analysing it. Internal fragments could
not be used since the peptide unfortunately contains
a mirror plane assuming that Ile and Leu cannot be
distinguished by the mass spectrometry. In the Ala-
peptide a peak corresponding to the immonium ion of
phospholysine was detected. This peak was also seen
in the His-peptide, and this supports the use of the
Ala-peptide as control peptide. Thus both lysines
could have been modiﬁed which also is in accordance
with results obtained by Kowalewska et al. (23).
The ratio in phosphorylation degree as determined
chemically between the two was conﬁrmed by mass
spectrometry. It should be mentioned that PHPT1
dephosphorylated Ac-Val-Arg-Leu-Lys(P)-Ala-Arg-
Lys(P)-Leu-Arg-pNA at about the same initial rate
as that of the background release of phosphate
at pH 8.0 from the phosphorylated Ala- or His-
containing peptide, i.e. 2–5 pmol/min.
The chemical phosphorylation of 0.09 mM histone
H4 was performed at the same low concentration of
phosphoramidate (3.9 mM) as used for the peptides.
The buffer, in which the recombinant histone H4 was
delivered, was shown to give variable and high phos-
phate backgrounds, probably since its high ionic con-
centration may have approached the binding capacity
of the DEAE-Sephacel column. This problem was
circumvented by changing the solvent before phos-
phorylation using micro spin columns equilibrated in
10 mM HCl. When mixed with the incubation
buffer, a pH of 7.8 was obtained for both the puriﬁed
and the recombinant form. The phosphorylation
was extended to 48 h in order to obtain the highest
possible phosphorylation (data not given). The chro-
matography on the DEAE-Sephacel micro spin col-
umn after the phosphorylation was performed at pH
8.5instead ofpH8.0inordertoincreasethestabilityof
both phosphoramidate and the phosphohistone prod-
uct. By using this protocol, the calf thymus histone
H4 puriﬁed from Sigma Histone Type II-S was phos-
phorylated to about 0.5 mol/mol as was the human
recombinant histone H4. The losses of histone during
centrifugation through each DEAE-Sephacel column
were in the range of 20% for both histone H4 forms.
Therefore a more exact ﬁgure could not be given.
Under the conditions used for isolation of phos-
phopeptides and phosphohistone H4, the phos-
phoramidate and any released orthophosphate were
completely bound to the DEAE-Sephacel. This was
ascertained after doubling the phosphoramidate
amount and measuring the sum of acid-labile phos-
phate and orthophosphate in the eluate from two
consecutive DEAE-Sephacel columns (420 mL fol-
lowed by 210 mL gel).Furthermore,no phosphate was
detected in the eluates at zero time of phosphoryla-
tion, which provides proof that neither phosphorami-
date nor any released orthophosphate stayed bound to
the basic peptides or to histone H4 during the passage
through the DEAE-Sephacel columns.
Dephosphorylation of Ac-Val-Arg-Leu-Lys-His(P)-
Arg-Lys-Leu-Arg-pNA
The dephosphorylation by recombinant PHPT1 of
24 mM phosphopeptide, in the presence of 136 mM
unphosphorylated peptide (phosphorylation degree
around 0.15 mol/mol), is described in Figure 2.
The net rate, as measured for the ﬁrst 10 minutes,
was essentially proportional to the PHPT1concentra-
tion and amounted to about 0.2 mol per second per
mol PHPT1.
That the dephosphorylation was essentially a
dephosphorylation of phosphohistidine was supported
by the fact that the phosphate bound to Ac-Val-Arg-
Leu-Lys-Ala-Arg-Lys-Leu-Arg-pNA (0.05 mol/mol)
was not detectably sensitive to PHPT1. In control
assays with no enzyme added a slow release of phos-
phate, 4 pmol/min (mean of three analyses), was seen
for both peptides. A dephosphorylation activity below
5 pmol/min is uncertain due to the sensitivity of the
phosphate analysis (0.0002 absorbance units/pmol)
under the conditions used.
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phosphopeptide concentration is shown in Figure 3.
An apparent Km was estimated to about 10 mM
Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA.
No Km is given in earlier works to compare with, but
the activity towards the peptide used in the present
work at least is in the same range as the activities for
the peptides derived from histone H4 described
by Attwood et al. (12). We compared in some
experiments the peptide substrate Suc-Ala-His(P)-
Pro-Phe-pNA (24 mM) used in Ek et al. (2) to
Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA
(8 mM). Both gave similar results using human
recombinant PHPT1 as enzyme (data not given).
It should be borne in mind that there was 85%
product present during the dephosphorylation reac-
tion. No product inhibition could be seen at a total
concentration of 0.6 mM of phosphorylated and
unphosphorylated peptide.
Forlargersetsofexperimentsduringalimitedtimeit
isworthpurifyingthephosphopeptidefromthemixture
by ion exchange chromatography. We deliberately
describe herein experiments that can easily be per-
formed on a more on and off basis, thereby avoiding
theproblemwithslowspontaneousdephosphorylation.
PHPT1 activity in liver cell sap
When cytosol from mouse liver prepared as described
in Ek et al. (2) was assayed for PHPT1 activity using
30 mM Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-
Arg-pNA (together with 170 mM unphosphorylated
peptide) as substrate, the activity was 2.4 mmolmin
-1
per mg of cytosol protein. This is similar to that found
earlier in porcine liver cytosol using 7 mM Suc-Ala-
His(P)-Pro-Phe-pNA as the substrate (2). It must,
however, be emphasized that the activity obtained
varied, probably due to the delicate balance between
phosphohistidine phosphorylation and dephosphory-
lation. The puriﬁcation procedure is more rapid when
small liver samples are used, which means that ATP
can still be present, thereby inﬂuencing this balance.
No degraded phosphopeptide, that might have
occurred during the incubation with mouse liver
cytosol, could be detected by mass spectrometry
analysis (MALDI-ms) in a sample where the Ac-
Val-Arg-Leu-Lys-His(P)-Arg-Lys-Leu-Arg-pNA was
dephosphorylated by 50%. The present method may
therefore be applicable to a screening for PHPT1 in
crude extracts.
Dephosphorylation of chemically phosphorylated
histone H4
Human recombinant histone H4 and calf thymus
histone H4 puriﬁed from histone Type II-S were,
after phosphorylation with phosphoramidate, used
0
0.1
0.2
0.3
0.4
0.5
0.6
02 04 06 08 0 1 0 0
Phosphorylated His-peptide (mM)
D
e
p
h
o
s
p
h
o
r
y
l
a
t
i
o
n
 
(
m
o
l
/
s
/
m
o
l
 
e
n
z
y
m
e
)
Figure 3. Activity of PHPT1 as a function of phosphopeptide
concentration. After phosphorylation of 2 mM Ac-Val-Arg-Leu-
Lys-His-Arg-Lys-Leu-Arg-pNA, phosphoramidate was removed by
centrifugation through DEAE-Sephacel as described in Material
and methods and diluted. The concentration of phosphopeptide
was determined in each sample. Puriﬁed PHPT1 (1 pmol) was
added to each concentration, and dephosphorylation was per-
formed at 30C in duplicate for 4, 8, and 12 min for each concen-
tration. The reaction was interrupted by centrifugation of 50 mL
through a spin column containing 210 mL DEAE-Sephacel equil-
ibrated in 25 mM Tris/HCl, pH 8.0. The phosphate in the ﬁnal
eluate was determined by malachite reagent and peptide by absor-
bance at 320 nm. Details are given in Material and methods. The
initial rate for each phosphopeptide concentration was plotted as a
function of phosphopeptide concentration. The experiment was
repeated three times with similar results.
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Figure 2. The PHPT1 activity as a function of enzyme concentra-
tion. The concentration of Ac-Val-Arg-Leu-Lys-His(P)-Arg-Lys-
Leu-Arg-pNA was 24 mM in this experiment, and the enzyme was
diluted 1/10 (&) and 1/20 (^), the former corresponding to
2.5 pmol per 50 mL incubation. The dephosphorylation was per-
formed at 30C and was interrupted by centrifugation of 50 mLo f
the reaction mixture through a spin column containing 210 mL
DEAE-Sephacel equilibrated in 25 mM Tris/HCl, pH 8.0. The
phosphate in the ﬁnal eluate was determined by malachite reagent
and peptide by absorbance at 320 nm. Details are given in Material
and methods.
166 U. Beckman-Sundh et al.as substrates for human recombinant PHPT1. The
result of one experiment is shown in Figure 4. As
measured at 15.7 mM phosphohistone in both cases,
the rate of dephosphorylation of phosphorylated,
puriﬁed histone H4 was 0.6 molsec
-1 per mol
PHPT1, while that of the phosphorylated recombi-
nant histone H4 was 0.3 molsec
-1 per mol. The
difference is further underlined by the fact that the
dephosphorylation rate for the phosphorylated, puri-
ﬁed H4 was higher despite its 2-fold lower phosphor-
ylation degree. The analyses were performed twice, so
these differences are probably not statistically signif-
icant since the phosphorylation and dephosphoryla-
tion varied in the order of 5% between different
experiments. A difference in the relative phosphory-
lation of His-18 and His-75 of either histone H4 or a
presence of an interfering post-translational modiﬁ-
cation in the puriﬁed calf thymus histone H4 may,
however, be considered.
Irrespective of the differences, the rates obtained
are remarkably high and are comparable to the rates
obtained for PHPT1 with the basic peptide in this
work as well as with the Suc-Ala-His(P)-Pro-Phe-
pNA used in a previous work by Ek et al. (2) and
histone H4-derived phosphopeptides studied by
Attwood et al. (12). This appears to be, by far, the
highest activity reported so far of a dephosphorylation
by PHPT1 of a histidine-phosphorylated protein and
promotes the possibility of using the method for other
highly positively charged molecules.
To the extent that the chemical phosphorylation of
histone H4 by phosphoramidate gives rise to phos-
phohistidines that are representative also of an in-vivo
phosphorylation of histone H4, the high rates of
dephosphorylation by PHPT1 reported here are of
signiﬁcant interest and open the possibility that at
least one type of phosphohistidine in histone H4 may
be a substrate for PHPT1 also in vivo.
Conclusion
This paper has described a new sensitive method for
the analysis of phosphohistidine phosphatase
(PHPT1). An essential advantage of the method is
its simplicity in both the preparation of the phosphor-
ylated labile substrate and the actual measurement of
the PHPT1-activity. The method was designed for the
use with substrates that remain highly basic even after
phosphorylation. Signiﬁcant rates of dephosphoryla-
tion by PHPT1 were displayed for chemically
phosphorylated histone H4 and a phosphopeptide
representing a phosphohistidine site of the potassium
channel KCa3.1. Although not the subject of the
present work, we venture to suggest that the prepar-
ative part of the method may be useful also in a search
for enzymatic phosphorylation of histone H4 and
basic, histidine-containing peptides, without a need
for radioactively labelled phosphate donors, since the
only limiting step for large-scale analysis is the cen-
trifuge(s) needed. The method can also facilitate the
search for inhibitors and activators to phosphohisti-
dine phosphatases like PHPT1. Efﬁcient inhibitors
would increase the sensitivity of the detection of
the histidine phosphorylating agents in crude cell
systems.
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